Evolution of the IgE and IgG repertoire to a comprehensive array of allergen molecules in the first decade of life

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 73, Issue 2, 2018, Pages 421-430

  Huang, X ^a,b   Tsilochristou, O ^a   Perna, S ^a   Hofmaier, S ^a   Cappella, A ^c   Bauer, C P ^d   Hoffman, U ^d   Forster, J ^e   Zepp, F ^f   Schuster, A ^g   D'Amelio, R ^c   Wahn, U ^a   Keil, T ^a,h   Lau, S ^a   Matricardi, P M ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b Shengzhou People's Hospital   (China)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^e Department of Internal Medicine and Cardiology St Josefs Hospital Freiburg   (Germany)

^f UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^g HEINRICH HEINE UNIVERSITY   (Germany)

^h UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

allergen molecule; birth cohort; Immunoglobulin E; Immunoglobulin G; microarray

Indexed keywords

ALLERGEN; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G;

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; BIRTH; CHILD; COHORT ANALYSIS; EVOLUTION; FEMALE; FOLLOW UP; HUMAN; IMMUNE RESPONSE; INFANT; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PHLEUM PRATENSE; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIZATION; AGE; BLOOD; CLINICAL TRIAL; GERMANY; IMMUNOLOGY; MULTICENTER STUDY; NEWBORN; PRESCHOOL CHILD;

AGE FACTORS; ALLERGENS; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; GERMANY; HUMANS; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; LONGITUDINAL STUDIES; MALE; PROSPECTIVE STUDIES;

EID: 85031087590     PISSN: 01054538     EISSN: 13989995     Source Type: Journal    
DOI: 10.1111/all.13269     Document Type: Article

References (45)

1. Johansson SG. IgE in allergic diseases. Proc R Soc Med. 1969;62:975-976.
2. Orgel HA, Hamburger RN, Bazaral M, et al. Development of IgE and allergy in infancy. J Allergy Clin Immunol. 1975;56:296-307.
3. http://www.who.int/features/factfiles/asthma/asthma_facts/en/
4. Platts-Mills TA, Woodfolk JA. Allergens and their role in the allergic immune response. Immunol Rev. 2011;242:51-68.
5. Bacher P, Heinrich F, Stervbo U, et al. Regulatory T Cell Specificity Directs Tolerance versus Allergy against Aeroantigens in Humans. Cell. 2016;167:1067-1078.
6. Curin M, Swoboda I, Wollmann E, et al. Microarrayed dog, cat, and horse allergens show weak correlation between allergen-specific IgE and IgG responses. J Allergy Clin Immunol. 2014;133:918-921.
7. Erwin EA, Hosen J, Pollart SM, Reid MJ, Platts-Mills TA. High-titer IgE antibody specific for pollen allergens in northern California is associated with both wheezing and total serum IgE. J Allergy Clin Immunol. 2009;123:706-708.
8. Thompson LF, Spiegelberg HL, Buckley RH. IgE Fc receptor positive T and B lymphocytes in patients with the hyper IgE syndrome. Clin Exp Immunol. 1985;59:77-84.
9. Turcanu V, Stephens AC, Chan SM, Rance F, Lack G. IgE-mediated facilitated antigen presentation underlies higher immune responses in peanut allergy. Allergy. 2010;65:1274-1281.
10. Platts-Mills TA, Schuyler AJ, Erwin EA, Commins SP, Woodfolk JA. IgE in the diagnosis and treatment of allergic disease. J Allergy Clin Immunol. 2016;137:1662-1670.
11. Groh N, von Loetzen CS, Subbarayal B, et al. IgE and allergen-specific immunotherapy-induced IgG4 recognize similar epitopes of Bet v 1, the major allergen of birch pollen. Clin Exp Allergy. 2017;5:693-703.
12. Pongpipat D, Tuchinda M. Serum IgE in Thai children with allergic diseases. J Med Assoc Thai. 1979;62:667-671.
13. Chang TW, Davis FM, Sun NC, Sun CR, MacGlashan DW Jr, Hamilton RG. Monoclonal antibodies specific for human IgE-producing B cells: a potential therapeutic for IgE-mediated allergic diseases. Biotechnology (N Y). 1990;8:122-126.
14. D'Amato G, Liccardi G, Noschese P, Salzillo A, D'Amato M, Cazzola M. Anti-IgE monoclonal antibody (omalizumab) in the treatment of atopic asthma and allergic respiratory diseases. Curr Drug Targets Inflamm Allergy. 2004;3:227-229.
15. Roxo P, Menezes UP, Tucci S Jr, Andrade MF, Silva GE, Melo JM. Renal abscess in hyper-IgE syndrome. Urology. 2013;81:414-416.
16. Aalberse RC. Specific IgE and IgG responses in atopic versus nonatopic subjects. Am J Respir Crit Care Med. 2000;162:S124-S127.
17. Platts-Mills TA, Vaughan JW, Blumenthal K, Pollart Squillace S, Sporik RB. Serum IgG and IgG4 antibodies to Fel d 1 among children exposed to 20 microg Fel d 1 at home: relevance of a nonallergic modified Th2 response. Int Arch Allergy Immunol. 2001;124:126-129.
18. Hesselmar B, Aberg B, Eriksson B, Bjorksten B, Aberg N. High-dose exposure to cat is associated with clinical tolerance–a modified Th2 immune response? Clin Exp Allergy. 2003;33:1681-1685.
19. Wachholz PA, Soni NK, Till SJ, Durham SR. Inhibition of allergen-IgE binding to B cells by IgG antibodies after grass pollen immunotherapy. J Allergy Clin Immunol. 2003;112:915-922.
20. Flicker S, Valenta R. Renaissance of the blocking antibody concept in type I allergy. Int Arch Allergy Immunol. 2003;132:13-24.
21. Aalberse R. The role of IgG antibodies in allergy and immunotherapy. Allergy. 2011;66(Suppl 95):28-30.
22. Jonsson F, Mancardi DA, Zhao W, et al. Human FcgammaRIIA induces anaphylactic and allergic reactions. Blood. 2012;119:2533-2544.
23. Finkelman FD, Khodoun MV, Strait R. Human IgE-independent systemic anaphylaxis. J Allergy Clin Immunol. 2016;137:1674-1680.
24. Chapman MD, Platts-Mills TA. Measurement of IgG, IgA and IgE antibodies to Dermatophagoides pteronyssinus by antigen-binding assay, using a partially purified fraction of mite extract (F4P1). Clin Exp Immunol. 1978;34:126-136.
25. Platts-Mills TA. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol. 1979;122:2218-2225.
26. Kolopp-Sarda MN, Moneret-Vautrin DA, Gobert B, et al. Specific humoral immune responses in 12 cases of food sensitization to sesame seed. Clin Exp Allergy. 1997;27:1285-1291.
27. Sverremark-Ekstrom E, Hultgren EH, Borres MP, Nilsson C. Peanut sensitization during the first 5 yr of life is associated with elevated levels of peanut-specific IgG. Pediatr Allergy Immunol. 2012;23:224-229.
28. Eysink PE, De Jong MH, Bindels PJ, et al. Relation between IgG antibodies to foods and IgE antibodies to milk, egg, cat, dog and/or mite in a cross-sectional study. Clin Exp Allergy. 1999;29:604-610.
29. Hofmaier S, Hatzler L, Rohrbach A, et al. “Default” versus “pre-atopic” IgG responses to foodborne and airborne pathogenesis-related group 10 protein molecules in birch-sensitized and nonatopic children. J Allergy Clin Immunol. 2015;135:1367-1374.
30. Schwarz A, Panetta V, Cappella A, et al. IgG and IgG4 to 91 allergenic molecules in early childhood by route of exposure and current and future IgE sensitization: Results from the Multicentre Allergy Study birth cohort. J Allergy Clin Immunol. 2016;138:1426-1433.
31. Bergmann RL, Bergmann KE, Lau-Schadensdorf S, et al. Atopic diseases in infancy. The German multicenter atopy study (MAS-90). Pediatr Allergy Immunol. 1994;5:19-25.
32. Hatzler L, Panetta V, Lau S. J Allergy Clin Immunol. 2012;130:894-901.
33. Posa D, Perna S, Resch Y, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol. 2017;2:541-549.
34. Illi S, von Mutius E, Lau S, et al. Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study. Lancet. 2006;368:763-770.
35. Asarnoj A, Ostblom E, Kull I, et al. Sensitization to inhalant allergens between 4 and 8 years of age is a dynamic process: results from the BAMSE birth cohort. Clin Exp Allergy. 2008;38:1507-1513.
36. Matricardi PM, Bockelbrink A, Gruber C, et al. Longitudinal trends of total and allergen-specific IgE throughout childhood. Allergy. 2009;64:1093-1098.
37. Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol. 2003;3:331-341.
38. Wawrzyniak M, O'Mahony L, Akdis M. Role of Regulatory Cells in Oral Tolerance. Allergy Asthma Immunol Res. 2017;9:107-115.
39. Matricardi PM. Allergen-specific immunoprophylaxis: toward secondary prevention of allergic rhinitis? Pediatr Allergy Immunol. 2014;25:15-18.
40. Kaiser L, Gronlund H, Sandalova T, et al. Production, crystallization and preliminary crystallographic study of the major cat allergen Fel d 1. Acta Crystallogr D Biol Crystallogr. 2003;59:1103-1105.
41. Rowntree S, Cogswell JJ, Platts-Mills TA, Mitchell EB. Development of IgE and IgG antibodies to food and inhalant allergens in children at risk of allergic disease. Arch Dis Child. 1985;60:727-735.
42. Kukkonen AK, Savilahti EM, Haahtela T, Savilahti E, Kuitunen M. Ovalbumin-specific immunoglobulins A and G levels at age 2 years are associated with the occurrence of atopic disorders. Clin Exp Allergy. 2011;41:1414-1421.
43. Looney TJ, Lee JY, Roskin KM. J Allergy Clin Immunol. 2016;137:579-586.
44. Xiong H, Dolpady J, Wabl M. Curotto de Lafaille MA, and Lafaille JJ, Sequential class switching is required for the generation of high affinity IgE antibodies. J Exp Med. 2012;209:353-364.
45. Erwin EA, Tripathi A, Ogbogu PU. J Allergy Clin Immunol Pract. 2015;3:896-904.